134 related articles for article (PubMed ID: 28981730)
21. Establishment and characterization of patient-derived cancer models of malignant peripheral nerve sheath tumors.
Oyama R; Kito F; Takahashi M; Hattori E; Noguchi R; Takai Y; Sakumoto M; Qiao Z; Toki S; Sugawara M; Tanzawa Y; Kobayashi E; Nakatani F; Iwata S; Yoshida A; Kawai A; Kondo T
Cancer Cell Int; 2020; 20():58. PubMed ID: 32099531
[TBL] [Abstract][Full Text] [Related]
22. CD70 antibody-drug conjugate as a potential therapeutic agent for uterine leiomyosarcoma.
Nakae R; Matsuzaki S; Serada S; Matsuo K; Shiomi M; Sato K; Nagase Y; Matsuzaki S; Nakagawa S; Hiramatsu K; Okazawa A; Kimura T; Egawa-Takata T; Kobayashi E; Ueda Y; Yoshino K; Naka T; Kimura T
Am J Obstet Gynecol; 2021 Feb; 224(2):197.e1-197.e23. PubMed ID: 32822640
[TBL] [Abstract][Full Text] [Related]
23. Oncogenic Gene-Expression Programs in Leiomyosarcoma and Characterization of Conventional, Inflammatory, and Uterogenic Subtypes.
Hemming ML; Fan C; Raut CP; Demetri GD; Armstrong SA; Sicinska E; George S
Mol Cancer Res; 2020 Sep; 18(9):1302-1314. PubMed ID: 32518213
[TBL] [Abstract][Full Text] [Related]
24. Synergistic effects of pazopanib and hyperthermia against uterine leiomyosarcoma growth mediated by downregulation of histone acetyltransferase 1.
Lin CY; Chao A; Wu RC; Lee LY; Ueng SH; Tsai CL; Lee YS; Peng MT; Yang LY; Huang HJ; Wang HS; Lai CH
J Mol Med (Berl); 2020 Aug; 98(8):1175-1188. PubMed ID: 32638047
[TBL] [Abstract][Full Text] [Related]
25. Primary leiomyosarcoma of the bone: a case report and a review of the literature.
Recine F; Bongiovanni A; Casadei R; Pieri F; Riva N; De Vita A; Mercatali L; Liverani C; Spadazzi C; Miserocchi G; Fausti V; Amadori D; Ibrahim T
Medicine (Baltimore); 2017 Nov; 96(45):e8545. PubMed ID: 29137065
[TBL] [Abstract][Full Text] [Related]
26. Molecular characterization and liposomal transfection of a p53-mutated cell line established from a poorly differentiated leiomyosarcoma.
Meye A; Bache M; Hinze R; Schmidt H; Würl P; Holzhausen HJ; Rath FW; Taubert H
Int J Oncol; 1998 Aug; 13(2):241-8. PubMed ID: 9664117
[TBL] [Abstract][Full Text] [Related]
27. Establishment and characterization of novel patient-derived extraskeletal osteosarcoma cell line NCC-ESOS1-C1.
Kito F; Oyama R; Noguchi R; Hattori E; Sakumoto M; Endo M; Kobayashi E; Yoshida A; Kawai A; Kondo T
Hum Cell; 2020 Jan; 33(1):283-290. PubMed ID: 31625124
[TBL] [Abstract][Full Text] [Related]
28. Primary leiomyosarcoma of bone: clinicopathologic, immunohistochemical, and molecular biologic aspects.
Wirbel RJ; Verelst S; Hanselmann R; Remberger K; Kubale R; Mutschler WE
Ann Surg Oncol; 1998; 5(7):635-41. PubMed ID: 9831113
[TBL] [Abstract][Full Text] [Related]
29. Differentiating soft tissue leiomyosarcoma and undifferentiated pleomorphic sarcoma: A miRNA analysis.
Guled M; Pazzaglia L; Borze I; Mosakhani N; Novello C; Benassi MS; Knuutila S
Genes Chromosomes Cancer; 2014 Aug; 53(8):693-702. PubMed ID: 24771630
[TBL] [Abstract][Full Text] [Related]
30. Establishment of novel patient-derived models of dermatofibrosarcoma protuberans: two cell lines, NCC-DFSP1-C1 and NCC-DFSP2-C1.
Oyama R; Kito F; Qiao Z; Sakumoto M; Shiozawa K; Toki S; Yoshida A; Kawai A; Kondo T
In Vitro Cell Dev Biol Anim; 2019 Jan; 55(1):62-73. PubMed ID: 30411273
[TBL] [Abstract][Full Text] [Related]
31. CSF1 expression in nongynecological leiomyosarcoma is associated with increased tumor angiogenesis.
Espinosa I; Edris B; Lee CH; Cheng HW; Gilks CB; Wang Y; Montgomery KD; Varma S; Li R; Marinelli RJ; West RB; Nielsen T; Beck AH; van de Rijn M
Am J Pathol; 2011 Oct; 179(4):2100-7. PubMed ID: 21854753
[TBL] [Abstract][Full Text] [Related]
32. MVP immunohistochemistry is a useful adjunct in distinguishing leiomyosarcoma from leiomyoma and leiomyoma with bizarre nuclei.
Lintel NJ; Luebker SA; Lele SM; Koepsell SA
Hum Pathol; 2018 Mar; 73():122-127. PubMed ID: 29307622
[TBL] [Abstract][Full Text] [Related]
33. Establishment and characterization of the NCC-SS1-C1 synovial sarcoma cell line.
Kito F; Oyama R; Takai Y; Sakumoto M; Shiozawa K; Qiao Z; Uehara T; Yoshida A; Kawai A; Kondo T
Hum Cell; 2018 Apr; 31(2):167-174. PubMed ID: 29450702
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of versican expression by siRNA facilitates tropoelastin synthesis and elastic fiber formation by human SK-LMS-1 leiomyosarcoma smooth muscle cells in vitro and in vivo.
Keire PA; Bressler SL; Mulvihill ER; Starcher BC; Kang I; Wight TN
Matrix Biol; 2016 Mar; 50():67-81. PubMed ID: 26723257
[TBL] [Abstract][Full Text] [Related]
35. Gene expression profiling in leiomyosarcomas and undifferentiated pleomorphic sarcomas: SRC as a new diagnostic marker.
Villacis RA; Silveira SM; Barros-Filho MC; Marchi FA; Domingues MA; Scapulatempo-Neto C; Aguiar S; Lopes A; Cunha IW; Rogatto SR
PLoS One; 2014; 9(7):e102281. PubMed ID: 25028927
[TBL] [Abstract][Full Text] [Related]
36. Establishment and characterization of a novel alveolar rhabdomyosarcoma cell line, NCC-aRMS1-C1.
Sin Y; Yoshimatsu Y; Noguchi R; Tsuchiya R; Sei A; Ono T; Toki S; Kobayashi E; Arakawa A; Sugiyama M; Yoshida A; Kawai A; Kondo T
Hum Cell; 2020 Oct; 33(4):1311-1320. PubMed ID: 32715445
[TBL] [Abstract][Full Text] [Related]
37. Bcl-2 receptor expression in patients with uterine smooth muscle tumors: an immunohistochemical analysis comparing leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma.
Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Mayerhofer K
J Soc Gynecol Investig; 2004 Apr; 11(3):187-91. PubMed ID: 15051039
[TBL] [Abstract][Full Text] [Related]
38. Targeting Hedgehog Pathway and DNA Methyltransferases in Uterine Leiomyosarcoma Cells.
Garcia N; Al-Hendy A; Baracat EC; Carvalho KC; Yang Q
Cells; 2020 Dec; 10(1):. PubMed ID: 33396427
[TBL] [Abstract][Full Text] [Related]
39. Targeted exome sequencing profiles genetic alterations in leiomyosarcoma.
Agaram NP; Zhang L; LeLoarer F; Silk T; Sung YS; Scott SN; Kuk D; Qin LX; Berger MF; Antonescu CR; Singer S
Genes Chromosomes Cancer; 2016 Feb; 55(2):124-30. PubMed ID: 26541895
[TBL] [Abstract][Full Text] [Related]
40. TJP1 Contributes to Tumor Progression through Supporting Cell-Cell Aggregation and Communicating with Tumor Microenvironment in Leiomyosarcoma.
Lee EY; Kim M; Choi BK; Kim DH; Choi I; You HJ
Mol Cells; 2021 Nov; 44(11):784-794. PubMed ID: 34764231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
